Literature DB >> 26837239

Impact of age on cytotoxic-induced ovarian failure in breast cancer treated with adjuvant chemotherapy and triptorelin.

Icro Meattini1, Calogero Saieva2, Fiammetta Meacci1, Vieri Scotti1, Carla De Luca Cardillo1, Isacco Desideri1, Valentina Baldazzi1, Monica Mangoni1, Silvia Scoccianti1, Beatrice Detti1, Gabriele Simontacchi1, Jacopo Nori3, Lorenzo Orzalesi4, Luis Sanchez4, Donato Casella4, Marco Bernini4, Massimiliano Fambrini5, Simonetta Bianchi6, Lorenzo Livi1.   

Abstract

AIM: This study analyzes our single-center, retrospective experience on 63 premenopausal breast cancer patients treated with monthly triptorelin and concomitant chemotherapy. PATIENTS &
METHODS: Concomitant chemotherapy and triptorelin were adopted as part of premature ovarian failure prevention strategy.
RESULTS: Age at diagnosis was the main factor influencing fertility preservation (p = 0.002). Compared with patients aged 41-45 years, the probability of menses resumption was almost threefold than for women aged 35-40 years, and significantly higher for women aged <35 years (hazard ratio: 9.0; p = 0.0001). The cumulative proportion among patients who resumed menses was 33.3% at 6 months, 75% at 12 months and 87.5% at 24 months. Seven patients attempted pregnancy, and five (71%) obtained healthy deliveries.
CONCLUSION: We observed an acceptable rate of fertility preservation. Age at diagnosis influences fertility preservation.

Entities:  

Keywords:  GnRH analogs; adjuvant treatment; breast cancer; concomitant chemotherapy; fertility preservation; premature ovarian failure; triptorelin

Mesh:

Substances:

Year:  2016        PMID: 26837239     DOI: 10.2217/fon.15.357

Source DB:  PubMed          Journal:  Future Oncol        ISSN: 1479-6694            Impact factor:   3.404


  3 in total

1.  Ovarian function after hematopoietic cell transplantation: a descriptive study following the use of GnRH agonists for myeloablative conditioning and observation only for reduced-intensity conditioning.

Authors:  R Phelan; E Mann; C Napurski; T E DeFor; A Petryk; W P Miller; J E Wagner; M R Verneris; A R Smith
Journal:  Bone Marrow Transplant       Date:  2016-06-06       Impact factor: 5.483

2.  Tracing and Characterizing the Development of Transplanted Female Germline Stem Cells In Vivo.

Authors:  Changqing Wu; Bo Xu; Xiaoyong Li; Wenzhi Ma; Ping Zhang; Xuejin Chen; Ji Wu
Journal:  Mol Ther       Date:  2017-05-18       Impact factor: 11.454

3.  Isolation of female germline stem cells from porcine ovarian tissue and differentiation into oocyte-like cells.

Authors:  Huy-Hoang Nguyen; Bui Le Quynh Nhu; Nguyen Nhat Phuong Uyen; Van-Thuan Nguyen; Hong-Thuy Bui
Journal:  J Reprod Dev       Date:  2019-08-04       Impact factor: 2.214

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.